UAE launches 6-monthly medication for schizophrenia
26 Jul 2026
Emirates Health Services (EHS) has announced the availability of BYANNLI, developed by Johnson & Johnson, for patients with schizophrenia at Al Amal Psychiatric Hospital, one of its affiliated facilities....
